Lung transplantation is the only effective treatment for end-stage lung disease. The scope of diagnosis and treatment focuses on the diseases including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, ɑ-1 antitrypsin deficiency, diffusing pulmonary cystic fibrosis, bronchiectasis, silicosis, idiopathic pulmonary hypertension, pulmonary lymphangioleiomyomatosis and other end-stage lung diseases.
Shanghai Chest Hospital is one of the earliest units in China to obtain qualification for lung transplantation. It is the unit to first perform lung transplantation in East China. In Shanghai, it was the earliest to promote the implementation of double lung transplantation and lung retransplantation. Relevant technologies and achievements won the second prize of Shanghai Clinical Medicine Achievements.
At present, the lung transplantation department has been built into a team with well-equipped supporting, mature surgical technology and multi-disciplinary cooperation. The lung transplantation operations carried out were including single lung transplantation, double lung transplantation, lobe transplantation and retransplantation. A total of nearly 100 cases of lung transplantation have been carried out, including four cases of lung re-transplantation. The patient with longest survival period of 11 years is still living in good condition. The oldest patient is 71 years old.